BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

504 related articles for article (PubMed ID: 27019287)

  • 21. Axillary reverse mapping (ARM): a new concept to identify and enhance lymphatic preservation.
    Thompson M; Korourian S; Henry-Tillman R; Adkins L; Mumford S; Westbrook KC; Klimberg VS
    Ann Surg Oncol; 2007 Jun; 14(6):1890-5. PubMed ID: 17479341
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Axillary reverse mapping: a prospective study in women with clinically node negative and node positive breast cancer.
    Connor C; McGinness M; Mammen J; Ranallo L; Lafaver S; Klemp J; Fan F; Mahnken J
    Ann Surg Oncol; 2013 Oct; 20(10):3303-7. PubMed ID: 23975287
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Optimal treatment of the axilla after positive sentinel lymph node biopsy in early invasive breast cancer. Early results of the OTOASOR trial].
    Sávolt A; Musonda P; Mátrai Z; Polgár C; Rényi-Vámos F; Rubovszky G; Kovács E; Sinkovics I; Udvarhelyi N; Török K; Kásler M; Péley G
    Orv Hetil; 2013 Dec; 154(49):1934-42. PubMed ID: 24292111
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Feasibility study of axillary reverse mapping for patients with clinically node-negative breast cancer.
    Noguchi M; Noguchi M; Ohno Y; Morioka E; Nakano Y; Kosaka T; Kurose N; Minato H
    Eur J Surg Oncol; 2016 May; 42(5):650-6. PubMed ID: 27005806
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Efficacy of Axillary Reverse Mapping for the Prevention of Lymphedema.
    Ruffino AE; Madera JD; Dearborn MM; Frank K; Oxenberg JC
    Am Surg; 2024 Feb; 90(2):199-206. PubMed ID: 37619219
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantifying the Impact of Axillary Surgery and Nodal Irradiation on Breast Cancer-Related Lymphedema and Local Tumor Control: Long-Term Results From a Prospective Screening Trial.
    Naoum GE; Roberts S; Brunelle CL; Shui AM; Salama L; Daniell K; Gillespie T; Bucci L; Smith BL; Ho AY; Taghian AG
    J Clin Oncol; 2020 Oct; 38(29):3430-3438. PubMed ID: 32730184
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is axillary reverse mapping feasible in breast cancer patients?
    Noguchi M; Miura S; Morioka E; Ohno Y; Yokoi-Noguchi M; Nakano Y; Kosaka T
    Eur J Surg Oncol; 2015 Apr; 41(4):442-9. PubMed ID: 25704555
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Axillary reverse mapping. preserving nodes during an axillary lymph node dissection].
    Gobardhan PD; Klompenhouwer EG; Beek MA; Voogd AC; Luiten EJ
    Ned Tijdschr Geneeskd; 2013; 157(22):A5646. PubMed ID: 23714290
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Arm morbidity following sentinel lymph node biopsy or axillary lymph node dissection: a study from the Danish Breast Cancer Cooperative Group.
    Husted Madsen A; Haugaard K; Soerensen J; Bokmand S; Friis E; Holtveg H; Peter Garne J; Horby J; Christiansen P
    Breast; 2008 Apr; 17(2):138-47. PubMed ID: 17928226
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Can axillary reverse mapping avoid lymphedema in node positive breast cancer patients?
    Tausch C; Baege A; Dietrich D; Vergin I; Heuer H; Heusler RH; Rageth C
    Eur J Surg Oncol; 2013 Aug; 39(8):880-6. PubMed ID: 23735162
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Identification and preservation of arm lymphatics in axillary lymph node dissection to prevent arm lymphedema: a single center randomized controlled trial].
    Yuan QQ; Wu GS; Hou JX; Zheng LW; Liao YQ; He YK
    Zhonghua Zhong Liu Za Zhi; 2022 May; 44(5):430-435. PubMed ID: 35615800
    [No Abstract]   [Full Text] [Related]  

  • 32. Axillary reverse mapping in patients undergoing axillary dissection -a short review of the literature.
    Noguchi M; Inokuchi M; Noguchi M; Morioka E; Kurita T
    Eur J Surg Oncol; 2020 Dec; 46(12):2218-2220. PubMed ID: 32912671
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Self-perceived, but not objective lymphoedema is associated with decreased long-term health-related quality of life after breast cancer surgery.
    Sackey H; Johansson H; Sandelin K; Liljegren G; MacLean G; Frisell J; Brandberg Y
    Eur J Surg Oncol; 2015 Apr; 41(4):577-84. PubMed ID: 25659877
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The clinical relevance of axillary reverse mapping (ARM): study protocol for a randomized controlled trial.
    Klompenhouwer EG; Gobardhan PD; Beek MA; Voogd AC; Luiten EJ
    Trials; 2013 Apr; 14():111. PubMed ID: 23782712
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Conservative axillary surgery is emerging in the surgical management of breast cancer.
    Noguchi M; Inokuchi M; Yokoi-Noguchi M; Morioka E; Haba Y
    Breast Cancer; 2023 Jan; 30(1):14-22. PubMed ID: 36342647
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements.
    McLaughlin SA; Wright MJ; Morris KT; Giron GL; Sampson MR; Brockway JP; Hurley KE; Riedel ER; Van Zee KJ
    J Clin Oncol; 2008 Nov; 26(32):5213-9. PubMed ID: 18838709
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Axillary reverse mapping in axillary surgery for breast cancer: an update of the current status.
    Beek MA; Gobardhan PD; Schoenmaeckers EJ; Klompenhouwer EG; Rutten HJ; Voogd AC; Luiten EJ
    Breast Cancer Res Treat; 2016 Aug; 158(3):421-32. PubMed ID: 27444925
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Axillary reverse mapping--chance to prevent lymphedema in breast cancer patients].
    Pavlista D; Koliba P; Eliska O
    Ceska Gynekol; 2011 Oct; 76(5):355-9. PubMed ID: 22132635
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Axillary reverse mapping for breast cancer.
    Noguchi M
    Breast Cancer Res Treat; 2010 Feb; 119(3):529-35. PubMed ID: 19842033
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: patient perceptions and precautionary behaviors.
    McLaughlin SA; Wright MJ; Morris KT; Sampson MR; Brockway JP; Hurley KE; Riedel ER; Van Zee KJ
    J Clin Oncol; 2008 Nov; 26(32):5220-6. PubMed ID: 18838708
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.